methotrexate has been researched along with EBV Infections in 158 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (1.27) | 18.2507 |
2000's | 53 (33.54) | 29.6817 |
2010's | 61 (38.61) | 24.3611 |
2020's | 42 (26.58) | 2.80 |
Authors | Studies |
---|---|
Asano-Mori, Y; Chiba, S; Hattori, K; Ishiwata, K; Izutsu, K; Kageyama, K; Kaji, D; Kusakabe, M; Makishima, K; Mitsuki, T; Nishida, A; Ota, Y; Sakata-Yanagimoto, M; Suehara, Y; Takagi, S; Taniguchi, S; Taya, Y; Ubara, Y; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yuasa, M | 1 |
Iwamoto, M; Kamata, Y; Nagashima, T; Nakamura, J; Saito, K; Sato, K; Sato, T; Yanagida, M | 1 |
Komoto, T; Mushiga, Y; Nagai, N; Ozawa, Y | 1 |
Banko, A; Cirkovic, A; Despotovic, A; Grk, M; Jeremic, I; Lazarevic, I; Miljanovic, D | 1 |
Fujioka, T; Hosoya, T; Kubota, K; Kumaki, Y; Mori, M; Nakagawa, T; Oda, G; Ogawa, A; Onishi, I; Uetake, H | 1 |
Chayama, K; Fujitaka, K; Hamada, H; Hattori, N; Horimasu, Y; Ito, N; Iwamoto, H; Masuda, T; Miyamoto, S; Nakashima, T; Sakamoto, S; Yamaguchi, K | 1 |
Ando, J; Ando, M; Komatsu, N; Ota, Y; Yasuda, H; Yoshida, S | 1 |
Ando, K; Carreras, J; Gion, Y; Kawada, H; Kikuti, YY; Kondo, Y; Nakamura, N; Ogawa, Y; Ohmachi, K; Sato, S; Sato, Y; Shiraiwa, S | 1 |
Altshuler, E; Franke, AJ; Holland, E | 1 |
Kumagai, J; Mochimatsu, Y; Ohgaki, F; Paku, S; Shuto, T; Takemoto, Y; Tatezuki, J | 1 |
Wang, J; Wang, Z; Yin, Q | 1 |
Fujii, H; Fujimoto, M; Haga, H; Hirata, M; Ikeo, S; Ikezoe, K; Minamiguchi, S; Morinobu, A; Nakamizo, S; Sugimoto, A; Takeuchi, Y; Usui, S; Yamada, Y | 1 |
Ishiguro, C; Kawashiri, A; Kurokawa, T; Maeda, Y; Mochizuki, K; Nakagawa, SI | 1 |
Teratani, Y; Watanabe, T | 1 |
Lefor, AK; Miyato, H; Omameuda, T; Sata, N | 1 |
Daa, T; Iwasaki, H; Kadowaki, M; Kawauchi, S; Kimura, S; Ogata, M; Oshiro, Y; Sakata, T; Takamatsu, Y; Takeshita, M; Wang, Z | 1 |
Nilius-Eliliwi, V; Schroers, R; Seidel, S; Treiber, H; Vangala, DB | 1 |
Ando, K; Ichinose, K; Imaizumi, Y; Itonaga, H; Kato, T; Miyazaki, Y; Miyoshi, H; Ohshima, K; Sato, S; Sawayama, Y | 1 |
D'Angelis, C; Powell, J; Quaye, EH | 1 |
Higashi, M; Iijima, Y; Kaneko, T; Kizaki, M; Momose, S; Sawada, K; Takahashi, T; Tamaru, JI; Yamamoto, W; Yamashita, T | 1 |
Fisher, R; Ieremia, E; Macklin, PS; Matin, RN; Stonard, C | 1 |
Bredemeier, M; Busato, VB; da Silveira, RG; de David Cruz, C; Provenzi, VO; Ritter, CG; Zamboni, S | 1 |
Carreras, J; Kikuti, YY; Kondo, Y; Moriya, K; Nakamura, N; Shiraiwa, S | 1 |
Delaleu, J; Dereure, O; Laroche, L; Lévy, A; Maubec, E; Rodrigues, F; Szablewski, V | 1 |
Akizuki, S; Fujimoto, M; Hashimoto, M; Hishizawa, M; Ishida, A; Kitagori, K; Murakami, K; Nakashima, R; Ohmura, K; Shindo, T; Tanaka, M; Tsuji, H; Yoshifuji, H | 1 |
Ando, K; Aoyama, Y; Carreras, J; Hara, R; Kawada, H; Kikuti, YY; Nakamura, N; Ogawa, Y; Ogiya, D; Ohmachi, K; Sato, S; Shiraiwa, S; Suzuki, R; Toyosaki, M | 1 |
Mochizuki, K; Nakamura, S; Oishi, N; Sato, Y; Satou, A; Suzuki, Y; Tabata, T; Tahara, I; Takahara, T; Tsuzuki, T; Yoshino, T | 1 |
Kang, YJ; Kim, YG; Lee, EJ; Lee, GM; Lee, HM; Lee, JH; Park, JH; Park, SH; Shin, S | 1 |
Aoyanagi, N; Endo, D; Kumazawa, K; Nagai, T; Nomura, M; Ono, H; Shimizu, A; Sumiya, R | 1 |
Fujii, T; Harigai, M; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M | 2 |
Fuji, S; Ohmoto, A | 1 |
Brandl, U; Feller, A; Frieling, D; von Wichert, G; Wernecke, M | 1 |
Fujimoto, M; Haga, H; Okada, M; Okuno, A; Takai, T | 1 |
Banno, S; Hanamura, I; Ito, Y; Iwagaitsu, S; Kohno, K; Nakamura, S; Nobata, H; Satou, A; Takahara, T; Takahashi, E; Takami, A; Tsuzuki, T; Watanabe, D | 1 |
Michaels, PD; Ramia de Cap, M | 1 |
Fukumura, M; Imai, R; Kameyama, K; Sasaki, A; Sasaki, H; Tsuda, N; Tsujikawa, H; Yoshida, K | 1 |
Cai, K; He, J; Manolios, N; Sturgess, A; Taper, J; Williamson, L; Wong, P | 1 |
Furukawa, M; Kachi, H; Kawaratani, H; Matsuura, K; Mitoro, A; Osaki, Y; Ozutsumi, T; Sawada, Y; Takagi, H; Tsuji, Y; Yamao, J; Yoshiji, H | 1 |
Gion, Y; Ikeda, T; Nishikori, A; Nishimura, MF; Nishimura, Y; Sato, Y; Yoshino, T | 1 |
Hamaguchi, M; Kitamura, N; Kobayashi, H; Nagasawa, Y; Sugiyama, K; Takei, M | 1 |
Ishibashi, S; Kizawa, M; Ohkubo, T; Sanjo, N; Sato, N; Toide, N; Yokota, T | 1 |
Amano, K; Anan-Nemoto, T; Higashi, M; Kizaki, M; Momose, S; Mori, T; Okamoto, S; Okuyama, A; Saito, S; Shimizu, T; Suzuki, K; Takeuchi, T; Tamaru, JI; Tokuhira, M | 1 |
Daa, T; Kohno, K; Moroga, Y; Nashimoto, Y; Ogata, M; Saburi, M; Shirao, K; Takano, K; Yoshida, N | 1 |
Asano, N; Daroontum, T; Eladl, AE; Kato, S; Kohno, K; Matsukage, S; Nakamura, S; Sakakibara, A; Satou, A; Ya-In, C; Yakushiji, N | 1 |
Ascani, S; Bisagni, A; De Marco, L; Froio, E; Mengoli, MC; Valli, R; Zanelli, M; Zizzo, M | 1 |
Matsuzaki, Y; Minakawa, S; Nakano, H; Sagara, C; Sawamura, D; Takiyoshi, N | 1 |
Banno, S; Hanamura, I; Ito, Y; Katsuno, T; Nakamura, S; Nobata, H; Satou, A; Takahara, T; Takahashi, E; Takami, A; Tsuzuki, T; Ueda, R | 1 |
Alpdogan, O; Gong, J; Palmisiano, N; Rhoades, R | 1 |
Fukushima, T; Hosaka, S; Imadome, KI; Imai-Saito, A; Iwabuchi, A; Jimbo, T; Kato, Y; Kobayashi, C; Kosaki, K; Masumoto, K; Nanmoku, T; Onodera, M; Saito, H; Sumazaki, R; Suzuki, R; Takada, H; Watanabe, N | 1 |
Goto, H; Mashima, A; Muramatsu, D; Umazume, K; Usui, Y | 1 |
Fujisaki, T; Kondo, S; Okamura, S; Oshiro, Y; Suematsu, E; Takeshita, M; Tamura, K; Tanimoto, K; Yamada, K; Yoshimoto, G | 1 |
Hakozaki, Y; Horikoshi, H; Kikuchi, Y; Kimura, F; Kobayashi, A; Kobayashi, S; Kondo, T; Masuoka, K; Matsuki, Y; Matsukuma, S; Nagumo, M; Oshima, S; Sato, K | 1 |
Monobe, Y; Ochi, N; Takigawa, N; Yamagishi, T; Yamane, H | 1 |
Ashlock, B; Bayraktar, S; Bayraktar, UD; Cabral, L; Diaz, LA; Dittmer, DP; Pereira, D; Ramos, JC; Toomey, N | 1 |
Blanchart, K; Chantepie, S; Charbonneau, P; Du Cheyron, D; Galateau-Salle, F; Paciencia, M; Seguin, A; Terzi, N | 1 |
Chang, JH; Cheong, JW; Hwang, DY; Hyun, SY; Jang, JE; Kim, JS; Kim, SH; Kim, SJ; Kim, Y; Kim, YR; Min, YH; Suh, CO | 1 |
Harada, A; Hodohara, K; Horinouchi, A; Ishida, M; Iwai, M; Kagotani, A; Nakanishi, R; Okabe, H; Okuno, H; Yoshida, K; Yoshida, T; Yoshii, M | 1 |
Kessler, HP; Naidu, A; Pavelka, MA | 1 |
Fujioka, Y; Kamma, H; Koji, H; Nakabayashi, K; Yamada, A; Yazawa, T | 1 |
Matsumoto, S; Mori, H; Ogata, M; Okada, F; Omote, E; Tokuyama, K; Urabe, S; Yamasaki, T | 1 |
Atta, J; Brandts, C; Brodt, HR; Kann, G; Kiderlen, T; Stephan, C; Wolf, T | 1 |
Johnson, RJ; Owen, RG; Sadasivam, N | 1 |
Fukunaga, A; Nagai, H; Nishigori, C; Oka, M; Shimoura, N | 1 |
Jansen, PM; Koens, L; Senff, NJ; Vermeer, MH; Willemze, R | 1 |
Harada, H; Ishii, Y; Kudoh, M; Matsumoto, K; Omura, K; Sato, Y | 1 |
Amorosa, V; Frank, D; Harrison, N; Shah, NN; Stonecypher, M; Svoboda, J | 1 |
Fukasawa, Y; Inokuma, D; Ito, T; Kikuchi, K; Moriuchi, R; Mukai, M; Murata, J; Shimizu, S | 1 |
Horie, N; Kaneko, T; Kawano, R; Shimoyama, T | 1 |
Fujisaki, T; Kondo, S; Nakayama, Y; Okamura, S; Oshiro, Y; Suematsu, E; Takeshita, M; Tamura, K; Yamada, K | 1 |
Fujii, T; Haruta, S; Hashimoto, M; Kaji, D; Matsuda, M; Ohkura, Y; Ota, Y; Shindoh, J; Watanabe, G | 1 |
Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
Asorey-García, A; García Sánchez, J; Santos-Bueso, E; Sastre-Ibáñez, M | 1 |
Eguchi, K; Fujishiro, D; Furukawa, H; Haneda, M; Kobayashi, A; Kodama, S; Komura, K; Makino, Y; Miyokawa, N; Mizumoto, K; Okamoto, K; Tani, C; Yoshimoto, R | 1 |
Rosen, D; Sinno, MG; Wittler, R | 1 |
Abinun, M; Flood, TJ; Foster, HE; Friswell, M; Lane, JP; Wood, M | 1 |
Ejima-Yamada, K; Fujisaki, T; Fukushige, T; Kojima, M; Mihashi, Y; Okamura, S; Oshiro, Y; Shibuya, K; Takeshita, M; Tamura, K | 1 |
Anei, R; Asanome, A; Hasebe, N; Kamada, K; Kano, K; Katayama, T; Miyokawa, N; Nishihara, H; Saito, M; Saito, T; Sawada, J; Takahashi, K; Takeguchi, S | 1 |
Aldridge, T; Brennan, PA; Ilankovan, V | 1 |
Barabareschi, M; Berti, A; Bortolotti, R; Felicetti, M; Guella, A; Morelli, L; Paolazzi, G; Peccatori, S; Vivaldi, P | 1 |
Kojima, M; Kusama, K; Sakashita, H; Shigematsu, H; Tanaka, A | 1 |
Nava, VE; Ozdemirli, M; Sartorelli, JS | 1 |
Matsuoka, H; Nakakuma, H; Nakamura, Y; Sonoki, T; Uneda, S | 1 |
Abinya, ON | 1 |
Chang, ST; Cho, CY; Chuang, SS; Hsiao, SC; Ichinohasama, R; Liao, YL; Lin, SH | 1 |
Damek, DM; Dogan, A; Giannini, C; Kleinschmidt-DeMasters, BK; Lillehei, KO | 1 |
Julian, BA; Kew, CE; Nabors, LB; Palmer, CA; Przekwas, AM | 1 |
Bautista, P; García-Del Moral, R; Kilmurray, LG; López-Chumillas, A; O'Valle, F; Pastor-Nieto, MA; Puig, AM | 1 |
Satoh, T; Shimura, C; Takayama, K; Yokozeki, H | 1 |
Ando, K; Bunno, M; Hatanaka, K; Irie, S; Kojima, M; Nakamine, H; Nakamura, N; Uekusa, T | 1 |
Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F | 1 |
Mok, MY; Trendell-Smith, NJ; Tsang, HH; Wu, AK | 1 |
Aozasa, K; Hatachi, S; Kunitomi, A; Yagita, M | 1 |
Daibata, M; Enzan, H; Hiroi, M; Kamioka, M; Nakaoka, Y; Nemoto, Y; Taniguchi, A; Yokoyama, A | 1 |
Kikuchi, K; Kojima, M; Kusama, K; Miyazaki, Y; Sakashita, H; Shigematu, H; Tanaka, A | 1 |
Avenel-Audran, M; Croué, A; Giard, C; Martin, L; Verret, JL | 1 |
Fukuhara, N; Harigae, H; Ichikawa, S; Ishizawa, K; Kameoka, J; Kohata, K; Nakajima, S; Okitsu, Y; Onishi, Y; Suzuki, M; Yamamoto, J | 1 |
Billings, SD; Hoschar, AP; McDonnell, JK; Rushing, EC | 1 |
Fujii, K; Kijima, C; Miyajima, Y; Oka, H; Utsuki, S; Yasui, Y | 1 |
Balaraman, B; Conley, JA; Sheinbein, DM | 1 |
Amano, K; Itoyama, S; Kameda, H; Kizaki, M; Mori, S; Nagasawa, H; Nemoto, T; Sagawa, M; Takeuchi, T; Tamaru, J; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
Ito, Y; Iwata, N; Kawada, J; Kimura, H; Kitagawa, Y | 1 |
Hashizume, H; Kawamura, T; Suda, T; Takigawa, M; Tokura, Y; Uchiyama, I | 1 |
Ardura, MI; Harker-Murray, P; Johnson-Welch, SF; Pokala, H; Seikaly, M; Twombley, K; Weinberg, A | 1 |
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M | 1 |
Attard, AA; Dunn, PJ; James, GJ; Praveen, P | 1 |
Baba, H; Ito, M; Izumi, Y; Kawakami, A; Kurohama, H; Migita, K; Mijin, T; Miyashita, T; Niino, D; Ohshima, K; Sakito, S; Toda, K; Tsustumi, K | 1 |
Fujimoto, M; Haga, H; Huang, CL; Kobashi, Y; Koyanagi, I; Sakashita, H; Yuba, Y | 1 |
Benhattar, J; Cairoli, A; de Leval, L; Hohl, D; Rausch, T; Spring, P | 1 |
Ito, Y; Iwata, N; Kawada, J; Kimura, H; Torii, Y | 1 |
Arranz, R; Cannata-Ortiz, J; García-Noblejas, A; Velasco, A | 1 |
Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
Brière, J; Dardenne, S; Detry, R; Emile, FJ; Fabiani, B; Gaulard, P; Guiot, Y; Michaux, L; Theate, I | 1 |
Berkow, RL; Hilliard, LM; Watts, RG | 1 |
Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B | 1 |
Chihara, K; Gomyo, H; Ito, M; Matsui, T; Minagawa, K; Okamura, A; Shimoyama, M; Urahama, N; Yakushijin, K; Yamamoto, K | 1 |
Cohen, JI; Delecluse, HJ; Feng, WH; Fischer, S; Goldbach-Mansky, R; Kenney, SC; Li, L; Raab-Traub, N; Sneller, M | 1 |
Eden, OB; Ng, A; Ravetto, PF; Taylor, GM; Wynn, RF | 1 |
Rocca, PV; Slease, RB; Vincent, S | 1 |
Castleberry, RP; Douglass, EC; Fontanesi, J; London, WB; Pappo, AS; Rodriguez-Galindo, C; Swanson, GP; Wofford, M | 1 |
Furuya, S; Hata, T; Higuchi, M; Hora, K; Hosaka, S; Ishizuka, O; Kamijo, Y; Kiyosawa, K; Nishizawa, O | 1 |
Bucuvalas, JC; Greiner, TC; Gross, TG; Hinrich, SH; Kaufman, SS; Langnas, AN; Lynch, JC; McDonald, RA; Park, JR; Ryckman, FC; Shaw, BW; Sudan, DL | 1 |
Leslie, WT; Loew, J; Rao, R; Venugopal, P; Vugman, G | 1 |
Heslop, HE | 1 |
Goto, T; Ito, R; Kawakami, K; Watanabe, Y | 1 |
Arrestier, S; Bouloudian, S; Dubost, JJ; Ristori, JM; Soubrier, M | 1 |
Hirabayashi, K; Igarashi, S; Itoh, H; Kashiwabara, K; Kojima, M; Masawa, N; Murayama, K; Nakamura, S; Ogura, H; Saitoh, R; Takimoto, J; Tamaki, Y | 1 |
Chim, CS; Mok, MY; Ooi, GC; Pang, YY; Shek, TW | 1 |
Whelan, P | 1 |
Abukawa, D; Ichinohazama, R; Imaizumi, M; Nakano, K; Sato, A; Takeyama, J | 1 |
Aozasa, K; Fujita, S; Hoshida, Y; Iizuka, A; Ikeda, J; Nakamichi, I; Nakatsuka, S; Takeuchi, T; Tamaru, J; Tomita, Y; Xu, JX | 1 |
Iizuka, A; Itoyama, S; Kameda, H; Okuyama, A; Takeuchi, T; Tamaru, J | 1 |
Herring, RA; Lee, DA; McClain, KL; Tatevian, N | 1 |
Benouaich-Amiel, A; Kaloshi, G; Khe, HX | 1 |
Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
Inagaki, T; Takeyama, J; Umebayashi, H | 1 |
Aiba, M; Kawauchi, K; Kimura, A; Ogasawara, T; Ohtuka, K; Yasuyama, M | 1 |
Fujimaki, K; Higashihara, M; Hotta, T; Ishigatsubo, Y; Kanamori, H; Kishi, K; Miyazaki, K; Miyazaki, T; Ohsaka, M; Sakai, R; Shirasugi, Y; Tamaru, J; Yamazaki, E; Yoshiba, F | 1 |
Abdallah-Lotf, M; de Muret, A; Machet, L; Machet, MC; Maruani, A; Wierzbicka, E | 1 |
Mariette, X; Miceli-Richard, C | 1 |
Dumortier, J; Fontana, A; Guillaud, O; Hot, A; Lapalus, MG; Miossec, P; Scoazec, JY | 1 |
McCullough, AE; Nguyen, BD; Roarke, MC | 1 |
Komatsuda, A; Nimura, T; Sawada, K; Wakui, H | 1 |
Gandhi, MK; Green, M; Griffiths, L; Hall, S; Nourse, J; Tran, H | 1 |
Chiefa, A; Curci, P; Delia, M; Liso, V; Rinaldi, E; Rizzi, R; Specchia, G | 1 |
Lane, JE; Parker, SR; Solomon, AR | 1 |
Munro, R; Porter, DR; Sturrock, RD | 1 |
Georgescu, L; Paget, SA | 1 |
Cohen, MD; Colon-Otero, G; Griesser, H; Lloyd, RV; Luthra, HS; Menke, DM; Moder, KG; Tefferi, A | 1 |
Allerberger, F; Gruber, J; Krugmann, J; Müller, T; Offner, FA; Sailer-Höck, M | 1 |
Hoekstra, JB; Van Den Bosch, JM; Van Gorp, JM; Van Haarlem, SW; Verpalen, MC | 1 |
Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
Dawson, TM; Gown, AM; Starkebaum, G; Willkens, RF; Wood, BL | 1 |
D'Incan, M; Déchelotte, P; Dubost, JJ; Franck, F; Soubrier, M; Souteyrand, P; Tournadre, A | 1 |
Doña Naranjo, MA; Riesco Díaz, M; Vargas Lebrón, C | 1 |
Starkebaum, G | 1 |
Cleary, AG; McDowell, H; Sills, JA | 1 |
Hirose, Y; Kawabata, H; Kim, CG; Masaki, Y; Ogawa, N; Okada, J; Sugai, S; Wano, Y | 1 |
24 review(s) available for methotrexate and EBV Infections
Article | Year |
---|---|
New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Databases, Factual; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Prevalence | 2022 |
Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
Topics: Aged; Arthritis, Rheumatoid; Central Nervous System; Disease Progression; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Plasmacytoma | 2023 |
Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; HIV Infections; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Methotrexate; Precancerous Conditions; Ulcer | 2023 |
Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature.
Topics: Aged; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Polymyositis | 2021 |
Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Topics: Animals; Disease Management; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunity; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Organ Transplantation | 2021 |
A case of central nervous system lesion pathologically characterized by angiocentric, T-cell-rich lymphoid cell infiltrates: a case report and literature review.
Topics: Adrenal Cortex Hormones; Adult; Central Nervous System; Central Nervous System Diseases; Chemoradiotherapy; Combined Modality Therapy; Epstein-Barr Virus Infections; Humans; Lymphomatoid Granulomatosis; Magnetic Resonance Imaging; Male; Methotrexate; T-Lymphocytes; Treatment Outcome | 2021 |
Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
Topics: Abatacept; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate | 2022 |
Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Gingival Diseases; Hodgkin Disease; Humans; Immunosuppressive Agents; Methotrexate; Oral Ulcer; Prednisone | 2014 |
Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature.
Topics: Aged; Biomarkers, Tumor; Biopsy; DNA, Viral; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; In Situ Hybridization; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Risk Factors; Skin Neoplasms | 2015 |
Epstein-Barr-virus-related mucocutaneous ulceration that mimics oral squamous cell carcinoma: the importance of recognising this new condition.
Topics: Aged, 80 and over; Antirheumatic Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Epstein-Barr Virus Infections; Humans; Immunohistochemistry; Male; Methotrexate; Mouth Neoplasms; Oral Ulcer; Prednisolone; Radiography, Panoramic | 2017 |
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Rheumatic Diseases; RNA, Viral | 2018 |
EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
Topics: Dermatologic Agents; Disease Progression; Epstein-Barr Virus Infections; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Psoriasis; Severity of Illness Index | 2009 |
[Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
Topics: Aged; Antigens, CD; Antigens, Neoplasm; Arthritis, Rheumatoid; Biomarkers, Tumor; Epstein-Barr Virus Infections; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Oral Ulcer; Remission Induction | 2009 |
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
Topics: Aged; Arthralgia; Cyclophosphamide; Deoxycytidine; Diphtheria Toxin; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisolone; Pruritus; Recombinant Fusion Proteins; Retrospective Studies; Skin Neoplasms; Stem Cell Transplantation; Vinblastine; Vincristine; Vinorelbine | 2011 |
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine | 2003 |
[Link between rheumatoid arthritis and cancer].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Cross-Sectional Studies; Epstein-Barr Virus Infections; Female; Hodgkin Disease; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms; Risk Factors; Tumor Necrosis Factor-alpha | 2006 |
[Primitif cerebral lymphoma].
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Biopsy; Brain; Brain Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Epstein-Barr Virus Infections; Eye Neoplasms; HIV Infections; Humans; Immunocompromised Host; Incidence; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 2006 |
Immunodeficiency-associated lymphomas.
Topics: Epstein-Barr Virus Infections; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunologic Deficiency Syndromes; Lymphoma; Methotrexate; Tumor Necrosis Factor-alpha; Virus Latency | 2008 |
Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Autoimmune Diseases; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Pulse Therapy, Drug; Remission, Spontaneous; Time Factors | 2009 |
Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Epstein-Barr Virus Infections; Female; Humans; Immunosuppression Therapy; Lymphoma; Male; Methotrexate; Middle Aged; Remission, Spontaneous; Risk Factors | 1999 |
Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Burkitt Lymphoma; Dermatologic Agents; Dermatomyositis; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; In Situ Hybridization; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; RNA, Viral; Skin | 2001 |
Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
Topics: Arthritis, Rheumatoid; Burkitt Lymphoma; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Risk | 2001 |
Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Juvenile; Child; Epstein-Barr Virus Infections; Humans; Lymphoma, B-Cell; Male; Methotrexate; Recurrence; Sentinel Lymph Node Biopsy; Treatment Outcome | 2002 |
4 trial(s) available for methotrexate and EBV Infections
Article | Year |
---|---|
Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Brain Neoplasms; Disease-Free Survival; DNA, Viral; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Retrospective Studies; RNA, Viral; Stem Cell Transplantation; Survival Rate; Vincristine | 2014 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult | 2012 |
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Fluorouracil; Herpesvirus 4, Human; Humans; Leucovorin; Methotrexate; Nasopharyngeal Neoplasms; Survival Rate | 2005 |
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Confidence Intervals; Cyclophosphamide; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Herpesvirus 4, Human; Humans; Infant; Lymphoproliferative Disorders; Male; Methotrexate; Organ Transplantation; Prednisone; Probability; Prospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
130 other study(ies) available for methotrexate and EBV Infections
Article | Year |
---|---|
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Histone-Lysine N-Methyltransferase; Hodgkin Disease; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Myeloid-Lymphoid Leukemia Protein; Prognosis; Progression-Free Survival; Proportional Hazards Models; Receptors, Tumor Necrosis Factor, Member 14; Retrospective Studies; Rheumatic Diseases; Tacrolimus; Tumor Necrosis Factor alpha-Induced Protein 3 | 2021 |
Epstein-Barr virus encephalitis in a patient with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Encephalitis; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Methotrexate; Middle Aged | 2022 |
Effects of intraocular treatments for Epstein-Barr virus (EBV) retinitis: A case report.
Topics: Adult; Epstein-Barr Virus Infections; Female; Foscarnet; Herpesvirus 4, Human; Humans; Methotrexate; Papilledema; Pulse Therapy, Drug; Retinitis; Steroids; Treatment Outcome | 2021 |
Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Liver Neoplasms; Lymphoproliferative Disorders; Meningoencephalitis; Methotrexate; Pneumonia; Reinfection; Valacyclovir | 2022 |
Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2023 |
9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
Topics: B7-H1 Antigen; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Methotrexate | 2022 |
Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
Topics: Adult; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Rituximab | 2022 |
Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Central Nervous System; Dexamethasone; Epstein-Barr Virus Infections; Ferritins; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Retrospective Studies | 2022 |
Fatal case of methotrexate-associated primary cutaneous extranodal NK/T-cell lymphoma of gamma delta phenotype.
Topics: Epstein-Barr Virus Infections; Humans; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Phenotype | 2022 |
Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia.
Topics: Antilymphocyte Serum; Azacitidine; Busulfan; Epstein-Barr Virus Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; HLA Antigens; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Tacrolimus; Transplantation Conditioning | 2022 |
Unusual manifestation of methotrexate-associated lymphoproliferative disorder as a palatal mass.
Topics: Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Palate | 2022 |
Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Topics: Antigens, CD; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Liver; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Necrosis | 2022 |
Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Topics: Arthritis, Rheumatoid; Disease Progression; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Killer Cells, Natural; Lymphoproliferative Disorders; Methotrexate; Prognosis; Tumor Suppressor Protein p53 | 2022 |
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Viral Diseases; Cytarabine; Epstein-Barr Virus Infections; Female; Humans; Lymphomatoid Granulomatosis; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2023 |
[Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2023 |
Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Ki-1 Antigen; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Methotrexate | 2023 |
EBV-positive mucocutaneous ulcer arising in methotrexate-treated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression.
Topics: Arthritis, Rheumatoid; B7-H1 Antigen; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Methotrexate; Ulcer | 2023 |
EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
Topics: Azathioprine; Conservative Treatment; Deprescriptions; Epstein-Barr Virus Infections; Facial Dermatoses; Female; Forehead; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Skin Ulcer | 2020 |
Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Composite Lymphoma; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Pharynx; Prednisone; Rituximab; Ulcer; Vincristine | 2020 |
Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.
Topics: Epstein-Barr Virus Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Methotrexate; Mycosis Fungoides; Skin Neoplasms | 2020 |
Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate | 2020 |
Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; B-Lymphocytes; Biomarkers, Tumor; Cell Differentiation; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Genes, Immunoglobulin Heavy Chain; Genes, T-Cell Receptor gamma; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Plasma Cells; Predictive Value of Tests; Risk Factors | 2021 |
Amplification of EBNA-1 through a single-plasmid vector-based gene amplification system in HEK293 cells as an efficient transient gene expression system.
Topics: Animals; CHO Cells; Cricetinae; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Amplification; Gene Expression; HEK293 Cells; Herpesvirus 4, Human; Humans; Methotrexate; Plasmids; Tetrahydrofolate Dehydrogenase | 2021 |
Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Topics: Aged, 80 and over; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Intestinal Perforation; Jejunum; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2021 |
Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case-control study.
Topics: Arthritis, Rheumatoid; Case-Control Studies; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Retrospective Studies | 2022 |
[EBV-positive MTX-associated lymphoproliferative disorder and Ig M myeloma in rheumatoid arthritis].
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Paraproteinemias | 2021 |
Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases.
Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Eruptions; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Skin Ulcer | 2021 |
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
Topics: Aged; Aged, 80 and over; Cohort Studies; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunophenotyping; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Remission Induction; Ulcer | 2021 |
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Japan; Lymphadenopathy; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies; Ulcer | 2022 |
High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Oral Ulcer; Prevalence; Receptors, Interleukin-2 | 2021 |
Small intestinal follicular lymphoma induced by methotrexate: a case report.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Jejunum; Lymphoma, Follicular; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2021 |
Epstein-Barr virus-positive mucocutaneous ulcer is characterized by relatively low serum soluble IL-2 receptor levels regardless of methotrexate use; Reply to Ramia de Cap and Michaels.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Methotrexate; Receptors, Interleukin-2; Ulcer | 2021 |
Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate | 2022 |
Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.
Topics: Adult; Epstein-Barr Virus Infections; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Neuromyelitis Optica | 2017 |
Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Survival Rate | 2018 |
Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Hepatitis, Viral, Human; Hodgkin Disease; Humans; Iatrogenic Disease; Infliximab; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 2018 |
Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Japan; Lymphoma; Male; Methotrexate; Middle Aged; Ulcer | 2018 |
Primary classic Hodgkin lymphoma of the ileum and Epstein-Barr virus mucocutaneous ulcer of the colon: two entities compared.
Topics: Adult; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Colonic Diseases; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Hodgkin Disease; Humans; Ileal Neoplasms; Immunocompromised Host; Immunohistochemistry; Immunosuppressive Agents; Male; Methotrexate; Opportunistic Infections; Predictive Value of Tests; Ulcer | 2019 |
Spontaneous remission of methotrexate-associated lymphoproliferative disorder with Epstein-Barr virus type II latency.
Topics: Aged, 80 and over; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Leg Ulcer; Lymphoproliferative Disorders; Methotrexate; Remission, Spontaneous | 2018 |
EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mouth Mucosa; Rituximab; Treatment Outcome; Ulcer | 2019 |
Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
Topics: Adult; Antimetabolites, Antineoplastic; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Herpesvirus 4, Human; HIV; HIV Infections; Humans; Male; Methotrexate; Plasmablastic Lymphoma; Rare Diseases; Sarcoma, Kaposi; Treatment Outcome | 2019 |
Establishment of immunity against Epstein-Barr virus infection in a patient with CHARGE/complete DiGeorge syndrome after peripheral blood lymphocyte transfusion.
Topics: CD3 Complex; Cell Proliferation; CHARGE Syndrome; Concanavalin A; Cyclosporine; Diarrhea; DiGeorge Syndrome; Epstein-Barr Virus Infections; Fatal Outcome; Graft vs Host Disease; Herpesvirus 4, Human; HLA Antigens; Humans; Infant, Newborn; Lymphocyte Transfusion; Male; Methotrexate; Mutation; Phenotype; Phytohemagglutinins; Siblings; T-Lymphocytes | 2019 |
Successful Treatment of Necrotizing Retinitis with Epstein-Barr Virus-Positive Ocular Fluid by Intravitreal Methotrexate Injection.
Topics: Aged, 80 and over; Aqueous Humor; DNA, Viral; Epstein-Barr Virus Infections; Eye Infections, Viral; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Intravitreal Injections; Methotrexate; Necrosis; Nucleic Acid Synthesis Inhibitors; Retinitis; Retrospective Studies; Treatment Outcome | 2020 |
Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Killer Cells, Natural; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies | 2013 |
Reversible iatrogenic, MTX-associated EBV-driven lymphoproliferation with histopathological features of a lymphomatoid granulomatosis in a patient with rheumatoid arthritis.
Topics: Aged; Antimetabolites, Antineoplastic; Arthritis, Rheumatoid; Cell Proliferation; Epstein-Barr Virus Infections; Humans; Iatrogenic Disease; Lymphomatoid Granulomatosis; Male; Methotrexate | 2013 |
Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis.
Topics: Aged; Arthritis, Rheumatoid; Biopsy, Needle; Contrast Media; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lung Neoplasms; Lymphomatoid Granulomatosis; Methotrexate; Polymerase Chain Reaction; Risk Assessment; Tomography, X-Ray Computed | 2013 |
Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell Line, Tumor; Combined Modality Therapy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine | 2014 |
Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Epstein-Barr Virus Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Immunophenotyping; Immunosuppressive Agents; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Mesenteric Ischemia; Methotrexate; Middle Aged; Pneumonia, Bacterial; Radiography; Respiratory Insufficiency | 2014 |
Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Gingiva; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate | 2013 |
CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2016 |
EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Contrast Media; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; In Situ Hybridization; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Positron-Emission Tomography; Radiographic Image Enhancement; Tomography, X-Ray Computed | 2014 |
Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Rituximab; Transplantation, Autologous; Treatment Outcome | 2014 |
Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
Topics: Aged; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Oral Ulcer | 2014 |
Epstein-Barr virus-associated methotrexate-induced accelerated rheumatoid nodulosis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; Lymph Nodes; Methotrexate; Rheumatoid Nodule; RNA, Viral; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
Topics: Aged; Aged, 80 and over; B-Lymphocytes; Biomarkers, Tumor; Cell Proliferation; Diagnosis, Differential; DNA, Viral; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Phenotype; Predictive Value of Tests; Risk Factors; Skin; Skin Neoplasms; Time Factors | 2014 |
Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; In Situ Hybridization; Lymphoproliferative Disorders; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Diagnostic Imaging; Doxorubicin; Early Diagnosis; Epstein-Barr Virus Infections; Etoposide; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine; Viremia | 2014 |
Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Gingival Neoplasms; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Oral Ulcer; Osteonecrosis | 2015 |
Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; In Situ Hybridization; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Receptors, Interleukin-2; Rituximab; RNA, Viral | 2015 |
Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy.
Topics: Adrenal Gland Neoplasms; Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Lymphoma; Male; Methotrexate; Virus Activation | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
[Denis Parsons Burkitt: A passion for knowledge].
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Dietary Fiber; Epidemiology; Epstein-Barr Virus Infections; Eye, Artificial; Filariasis; Gastrointestinal Diseases; General Surgery; Herpesvirus 4, Human; History, 20th Century; Humans; Ireland; London; Medical Missions; Medical Oncology; Methotrexate; Uganda | 2015 |
Multiple Intestinal Ulcers Associated with Primary Epstein-Barr Virus Infection in a Patient with Rheumatoid Arthritis Undergoing Methotrexate Therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Ileal Diseases; Ileum; Immunocompromised Host; Intestinal Diseases; Intestinal Mucosa; Methotrexate; Treatment Outcome; Ulcer | 2015 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.
Topics: Adenovirus Infections, Human; Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Bacteremia; Catheter-Related Infections; Central Venous Catheters; Child; Epstein-Barr Virus Infections; Fatal Outcome; Female; Humans; Methotrexate; Multiple Organ Failure; Sepsis; Staphylococcal Infections; Treatment Outcome; Tumor Necrosis Factor-alpha; Viremia | 2016 |
Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; CpG Islands; DNA Methylation; Epstein-Barr Virus Infections; Female; Genetic Markers; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Promoter Regions, Genetic; Treatment Outcome | 2017 |
Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Brain; Central Nervous System; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Vasculitis | 2017 |
Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease.
Topics: Adult; Antirheumatic Agents; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Maxillary Diseases; Methotrexate; Still's Disease, Adult-Onset | 2008 |
Maxillary angiocentric EBV-associated large B cell lymphoma associated with methotrexate treatment.
Topics: Antirheumatic Agents; Epstein-Barr Virus Infections; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Maxillary Neoplasms; Methotrexate; Middle Aged | 2008 |
Rapid vanishing of tumors by withdrawal of methotrexate in Epstein-Barr virus-related B cell lymphoproliferative disorder.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Immune System; Lymphoma, B-Cell; Methotrexate; Mouth Neoplasms; Thoracic Neoplasms; Tomography, X-Ray Computed | 2008 |
Burkitt's lymphoma-- what is new?
Topics: Africa; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; Child; Cyclophosphamide; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; Malaria; Male; Methotrexate; Rituximab; Vincristine | 2008 |
Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; CD3 Complex; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Female; Humans; Immune Tolerance; Immunoglobulin Heavy Chains; Immunosuppressive Agents; Lymphoma; Male; Methotrexate; Rituximab; Tomography Scanners, X-Ray Computed | 2008 |
Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.
Topics: Central Nervous System Diseases; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Transplantation; Methotrexate; Myeloproliferative Disorders; Postoperative Complications; Transplantation, Homologous; Treatment Outcome | 2009 |
Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
Topics: Aged, 80 and over; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Skin Diseases | 2009 |
Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Lymphoproliferative Disorders; Male; Methotrexate | 2010 |
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Mycosis Fungoides; Prednisone; Sezary Syndrome; Skin Neoplasms | 2011 |
Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Mycophenolic Acid; Rituximab | 2010 |
CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Topics: Acyclovir; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunophenotyping; Lymph Nodes; Lymphoproliferative Disorders; Meningoencephalitis; Methotrexate; Methylprednisolone | 2010 |
Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Humans; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Panniculitis | 2010 |
Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Mouth; RNA, Viral | 2010 |
Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
Topics: Adrenal Cortex Hormones; Aged; Dermatologic Agents; Dermatomyositis; Epstein-Barr Virus Infections; Female; Humans; Immunoglobulins, Intravenous; Immunohistochemistry; Lymphoma, B-Cell; Methotrexate; Prednisolone; Skin Neoplasms | 2010 |
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Injections, Spinal; Leukemia, Large Granular Lymphocytic; Leukemic Infiltration; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Prednisone; Radiography; Remission Induction; Subarachnoid Hemorrhage; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2010 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time?
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System; Central Nervous System Neoplasms; Comorbidity; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; In Situ Hybridization; Incidence; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Retrospective Studies; RNA, Viral; Treatment Outcome | 2011 |
Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD20; Antirheumatic Agents; Arthritis, Rheumatoid; Chromosome Aberrations; Epstein-Barr Virus Infections; Female; Flow Cytometry; Humans; Immunocompromised Host; Immunohistochemistry; Karyotype; Ki-1 Antigen; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prognosis; Survival Analysis | 2012 |
Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Male; Methotrexate; Prospective Studies; Viral Load; Virus Activation | 2012 |
Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
Topics: Antiviral Agents; Epstein-Barr Virus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Oral Ulcer; Polymyositis | 2012 |
Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Central Nervous System Diseases; Dexamethasone; Drug Therapy, Combination; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunologic Factors; Infusions, Intraventricular; Kidney Transplantation; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methotrexate; Postoperative Complications; Prognosis; Rituximab; Seizures; Treatment Outcome | 2012 |
Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Breast Neoplasms; Diagnosis, Differential; DNA, Viral; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Medical History Taking; Methotrexate; Oral Ulcer | 2012 |
Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.
Topics: Abatacept; Antirheumatic Agents; Arthritis, Rheumatoid; Brain Neoplasms; Epstein-Barr Virus Infections; Female; Humans; Immunoconjugates; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Retreatment; Treatment Outcome | 2013 |
Coexistence of Epstein-Barr virus-associated lymphoproliferative disorder and marginal zone B-cell lymphoma of the thymus in a patient with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cell Transformation, Neoplastic; Comorbidity; Epstein-Barr Virus Infections; Humans; Lymphocytes; Lymphoma, B-Cell, Marginal Zone; Lymphoproliferative Disorders; Male; Methotrexate; Plasma Cells; Thymectomy; Thymus Neoplasms | 2012 |
EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.
Topics: Aged; Biopsy; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunohistochemistry; Leg; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Mycosis Fungoides; Skin Neoplasms | 2013 |
Remission of juvenile idiopathic arthritis with primary Epstein-Barr virus infection.
Topics: Arthritis, Juvenile; Child, Preschool; Cytokines; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Remission, Spontaneous; Risk Assessment; Sampling Studies; Severity of Illness Index | 2013 |
[Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
Topics: Aged; Arthritis, Psoriatic; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunophenotyping; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Methotrexate; Neoplasm Proteins; Oral Ulcer; Remission, Spontaneous | 2013 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone.
Topics: Anti-Inflammatory Agents; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Middle Aged; Sarcoidosis, Pulmonary | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Effective anti-viral therapy for hemophagocytic syndrome associated with B-cell lymphoma.
Topics: Acyclovir; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Lymphoma, B-Cell; Methotrexate; Syndrome | 2003 |
Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Topics: Arthritis, Rheumatoid; Cell Line, Tumor; DNA, Viral; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma; MAP Kinase Kinase Kinases; Methotrexate; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Polymyositis; Promoter Regions, Genetic; Signal Transduction; Viral Load | 2004 |
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Dexamethasone; DNA-Binding Proteins; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Histiocytosis, Non-Langerhans-Cell; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nucleic Acid Synthesis Inhibitors; Polymerase Chain Reaction; Proto-Oncogenes; Time Factors; Topoisomerase II Inhibitors; Transcription Factors | 2004 |
Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Interactions; Epstein-Barr Virus Infections; Female; Humans; Lactones; Lymphoproliferative Disorders; Methotrexate; Sulfones | 2002 |
Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
Topics: Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Cadaver; Combined Modality Therapy; Epstein-Barr Virus Infections; Humans; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Postoperative Complications | 2005 |
Lymphomatoid granulomatosis treated with rituximab and chemotherapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Cortex; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epilepsy, Tonic-Clonic; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunotherapy; Lung Neoplasms; Lymphomatoid Granulomatosis; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine; Vision Disorders | 2003 |
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
Topics: Epstein-Barr Virus Infections; Graft Rejection; Herpesvirus 4, Human; HIV Infections; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Immunotherapy; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Transplantation; Virus Latency | 2005 |
[Effective treatment for a methotrexate-associated lymphoproliferative disorder with R-CHOP following administration of rituximab].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Opportunistic Infections; Prednisolone; Rituximab; Vincristine | 2005 |
Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disease-Free Survival; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Liver Neoplasms; Lymphoma, B-Cell; Methotrexate; Middle Aged; Withholding Treatment | 2006 |
Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases.
Topics: Aged; Antimetabolites, Antineoplastic; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Immunohistochemistry; In Situ Hybridization; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prevalence; RNA, Viral | 2006 |
EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Knee Joint; Lymphoma, B-Cell; Male; Methotrexate | 2006 |
Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppressive Agents; Methotrexate; Naproxen; Prednisone; Time Factors; Tumor Virus Infections | 2006 |
Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoenzyme Techniques; Immunophenotyping; Immunosuppressive Agents; In Situ Hybridization; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Neoplasm Staging; Organ Transplantation; RNA, Viral; Survival Rate | 2007 |
Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Fatal Outcome; Humans; Immunosuppressive Agents; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Male; Methotrexate; Pneumonia; Pulmonary Alveoli | 2007 |
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunocompromised Host; Infant; Lymphoma, Large B-Cell, Diffuse; Mercaptopurine; Methotrexate; Mycoses; Prednisone; Recurrence; Rituximab; Vinblastine; Vincristine; Virus Activation | 2008 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematuria; Hodgkin Disease; Humans; Kidney Diseases; Methotrexate; Methylprednisolone; Prednisolone; Proteinuria; Sulfasalazine; Treatment Outcome | 2007 |
[2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Rectal Neoplasms; Remission Induction; Time Factors | 2007 |
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Risk Assessment; Treatment Outcome | 2007 |
Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Remission Induction; Skin Diseases | 2007 |
EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Virus Activation | 2007 |
Epstein Barr virus-induced hepatitis associated with methotrexate treatment.
Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Liver Function Tests; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Serologic Tests | 2008 |
Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Cyclophosphamide; Dermatomyositis; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Prednisone; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2008 |
Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Glucocorticoids; Humans; Immunocompromised Host; Infliximab; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Prednisolone | 2008 |
A report of Epstein-Barr virus-positive primary cutaneous natural killer-/T-cell lymphoma.
Topics: Administration, Oral; Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Female; Humans; Killer Cells, Natural; Lymphocyte Subsets; Lymphoma, T-Cell, Cutaneous; Methotrexate; Middle Aged; Skin | 2008 |
Lymphadenopathy in a patient with systemic onset juvenile chronic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Diagnosis, Differential; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Methotrexate | 1998 |
Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate.
Topics: Adolescent; Adult; Connective Tissue Diseases; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; In Situ Hybridization; Lymphoma; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2000 |
Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Infant; Legionnaires' Disease; Methotrexate | 2000 |
An Epstein-Barr virus-associated pulmonary lymphoproliferative disorder as complication of immunosuppression.
Topics: Arthritis, Rheumatoid; Biopsy, Needle; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Neoplasms; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Risk Factors; Tomography, X-Ray Computed | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; In Situ Hybridization; Lymph Nodes; Lymphoma; Male; Methotrexate; Middle Aged; RNA, Viral; Sjogren's Syndrome | 2001 |
[Regression of Epstein-Barr virus associated lymphoma after methotrexate and cyclosporine A withdrawal in a patient with rheumathoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged | 2001 |
Epstein-Barr virus-associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate.
Topics: Arthritis, Rheumatoid; DNA, Neoplasm; Epstein-Barr Virus Infections; Genome, Viral; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Tumor Suppressor Protein p53 | 2002 |